The DC Universe is set to debut its third major franchise film, Clayface, on October 23. Starring Tom Blyth, the production explores the origins of the shapeshifting villain by combining the histories of Basil Karlo and Matt Hagen.
Tracing the lineage from 1940's Detective Comics to the 1961 Hagen debut
The character of Clayface has been a staple of Batman’s rogues gallery for over eight decades, beginning with an appearance in 1940’s Detective Comics #40. Historically, the mantle has been shared by multiple individuals, most notably Basil Karlo and Matt Hagen. As the source reports, Matt Hagen first entered the fray in 1961’s Detective Comics #298.. This long history provides a rich foundation for the DCU's attempt to center a feature film on a single, complex antagonist.
This move follows a growing cinematic trend of exploring the psychological motivations of Batman's enemies, a path paved by the two Joker films starring Joaquin Phoenix. By focusing on a single character's desecnt, the DCU is signaling a shift toward character-driven tragedy rather than traditional superhero spectacle.
Tom Blyth's Hagen and the gangster-driven disfigurement
In this new cinematic iteration, the film will blend the identities of Karlo and Hagen into a single narrative arc. Tom Blyth will portray Matt Hagen, but with a twist: rather than being a treasure hunter, this version of the character is an actor. The plot centers on Hagen undergoing an experimental treatment to repair his appearance after being disfigured by an angry gangster.
The production also features Naomi Ackie and Max Minghella in key roles, though their specific character motivations remain under wraps . By centering the story on a professional actor's loss of identity,the film appears to be leaning into the "tragic villain" arhetype that has defined the character in previous media.
The Renuyu cream and the influence of Ron Perlman's 1992 performance
The creative direction of the film draws significant inspiration from the 1990s era of DC animation. According to the report, co-writer Mike Flanagan was inspired by his work on Batman: The Animated Series, specifically the "Feat of Clay" episodes that aired in September 1992. In those classic episodes, voiced by Ron Perlman, Hagen’s transformation was tied to an experimental drug called Renuyu cream provided by Roland Daggett.
This animated history established a pattern of tragedy where the villain's powers are a direct consequence of a desperate attempt to reclaim a lost life. The connection to Perlman’s iconic performance suggests that the new film will prioritize the emotional weight of Hagen's transformation over simple science-fiction spectacle.
The missing roles of Naomi Ackie and Max Minghella
While the source provides a deep dive into the character's history, several key details regarding the upcoming October 23 release remain unconfirmed. It is currently unclear how Naomi Ackie and Max Minghella fit into the narrative or if they will portray characters from the established animated lore, such as Dr.. Stella Bates.
Furthermore, the report does not specify if the film will incorporate specific elements like Daggett Industries or the Wayne Biomedical isotope MP-40. Without confirmation on whether the movie will be a direct adaptation of the Batman: The Animated Series plot or a completely new origin, audiences are left to wonder how much of the 1992 tragedy will be present in this live-action version.
Comments 0